AMOEBA (EPA:AMEBA) - Amoéba: STÄHLER SUISSE SA EVALUATES AMOEBA BIOCONTROL PRODUCTS ON GRAPES AND POTATOES
Transparency directive : regulatory news
Click here to download pdf version
STÄHLER SUISSE SA EVALUATES AMOEBA BIOCONTROL PRODUCTS ON GRAPES AND POTATOES
Chassieu (France), March 25, 2020 - AMOEBA (FR0011051598 - AMEBA), producer of
a biological biocide capable of eliminating the risk in water and human wounds,
and of a biocontrol product for plant protection, still in the testing phase,
announces the signature of a Material Transfer Agreement (MTA) with STÄHLER
SUISSE SA. This partnership with one of the leading distributors of plant
protection products and biocontrol solutions in Switzerland, aims to extend the
performance assessment of Amoéba's biocontrol products on grapes and
The purpose of the research partnership is the delivery by Amoeba of
experimental products containing the amoeba lysate Willaertia magna C2c Maky.
In return, STÄHLER SUISSE SA will carry out its own field trials in order to
assess the performance of these products in preventing essential diseases
specific to the crops tested.
Amoéba and STÄHLER SUISSE SA are thus starting a targeted research phase
which could lead to the commercial development of Amoéba's biocontrol
solutions if it proves to be successful.
"Our market is in demand for innovative crop protection solutions that are both
effective and environmentally friendly. This is the case with Amoéba's
biocontrol products and STÄHLER SUISSE SA hopes to extend this partnership to
other promising solutions for tomorrow's agriculture. " says Simon Gasser, Head
of Development and Registration at STÄHLER SUISSE SA.
"Amoéba's closer ties with the major players in crop protection, such as
Stähler Suisse SA, are part of Amoéba's development strategy for its
biocontrol business. These trials offer significant potential for the company
and are an essential step towards a possible commercial partnership," explains
Fabrice Plasson, Chairman and CEO of Amoéba.
Amoéba recalls that the company is still in the testing phase for its biocide
and biocontrol applications and does not currently market any products.
About STÄHLER SUISSE SA
STÄHLER SUISSE SA is one of the leading distributors of crop protection
products and biocontrol solutions in Switzerland, with a strong specialization
on grapes and other valuable fruit and vegetables as well as all field crops.
The mission of STÄHLER SUISSE SA covers the development, registration and
marketing of plant protection products for professional and non-professional
markets. STÄHLER SUISSE SA is an independent Swiss company which equity is
held by its management, thus guaranteeing the implementation of a long-term
strategy for the business conduct.
Stähler Suisse SA
Responsable Développement et régistration
41 (0)62 746 80 05
Amoéba's ambition is to become a major player in the treatment of bacterial
risk in the fields of water, healthcare and plant protection. Our biological
solution is an alternative to chemical products widely used today. Amoéba is
currently focusing on the market of industrial cooling towers estimated at
EUR1.7Bn (1) on a global chemical biocide market for water treatment, evaluated
at EUR21Bn (2) and on the biocontrol market for plant protection estimated
globally at EUR1.6Bn (4). In the future, the Company is looking at developing
new applications such as chronic wound care, estimated at EUR 751 million (3)
in the USA. Sales of associated products with healthcare, biocides and crop
protection are subject to the Company being granted local regulatory market
authorizations. The Company is currently in a trial phase for biocidal and
plant protection applications and does not market any products.
Created in 2010, based in Chassieu (Lyon, France) with a subsidiary in Canada
and in the United States, Amoéba is quoted on the compartment C of Euronext
Paris. The Company is a member of the BPIfrance Excellence network and is
eligible for the PEA-PME SME equity savings plan setup. More information on
(1) : Amoéba data combined from sources: DRIRE 2013, Eurostat, ARHIA 2013
(2) : Sources combined by Amoéba from water treaters, Freedonia, Eurostat et
(3): BCC Research, "Markets for Advanced Wound Management Technologies,"
Wellesley, MA, 2017
(4): Biopesticides Worldwide Market 2013, CPL, Wallingford, UK
+33 (0)4 26 69 16 00
Investors and Media Relations
Grégory BOSSON / Mathieu CALLEUX
+33(0)1 53 65 37 90
This press release contains certain forward-looking statements concerning
AMOEBA which are based on its own assumptions and hypothesis and on information
that are available to us. However, AMOEBA gives no assurance that the estimates
contained in such forward-looking statements will be verified, which estimates
are subject to numerous risks including the risks set forth in the reference
document of AMOEBA filed with the French Financial Markets Authority (Autorité
des Marchés Financiers) on April 25, 2019 under number D19-0383 (a copy of
which is available on www.amoeba-biocide.com). The forward-looking statements
contained in this press release are also subject to risks not yet known to
AMOEBA or not currently considered material by AMOEBA. The occurrence of all or
part of such risks could cause actual results, financial conditions,
performance or achievements of AMOEBA to be materially different from such